Acadian Asset Management LLC Edwards Lifesciences Corp Transaction History

Acadian Asset Management LLC

$32.2 Billion
Q3 2024

A detailed history of Acadian Asset Management LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Acadian Asset Management LLC holds 44,433 shares of EW stock, worth $3.07 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

44,433

Previous 88,803 49.96%

Holding current value

$3.07 Million

Previous $8.2 Million 64.27%

% of portfolio

0.01%

Previous 0.03%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$59.7 - $93.78 $2.65 Million - $4.16 Million	-44,370 Reduced 49.96%	44,433 $2.93 Million
Q2 2024 Aug 06, 2024	BUY	$84.3 - $94.31 $6.11 Million - $6.83 Million	72,458 Added 443.3%	88,803 $8.2 Million
Q1 2024 May 10, 2024	SELL	$72.54 - $95.56 $1.76 Million - $2.31 Million	-24,197 Reduced 59.68%	16,345 $1.56 Million
Q4 2023 Feb 13, 2024	BUY	$61.71 - $77.76 $1.66 Million - $2.1 Million	26,977 Added 198.87%	40,542 $3.09 Million
Q3 2023 Nov 13, 2023	SELL	$69.28 - $93.38 $1.3 Million - $1.75 Million	-18,729 Reduced 58.0%	13,565 $938,000
Q2 2023 Aug 07, 2023	SELL	$81.41 - $94.33 $2.12 Million - $2.46 Million	-26,055 Reduced 44.65%	32,294 $3.04 Million
Q1 2023 May 11, 2023	SELL	$74.26 - $84.51 $20.9 Million - $23.8 Million	-281,686 Reduced 82.84%	58,349 $4.82 Million
Q4 2022 Feb 14, 2023	BUY	$68.3 - $87.44 $21.4 Million - $27.4 Million	313,236 Added 1168.83%	340,035 $25.4 Million
Q3 2022 Nov 14, 2022	SELL	$82.37 - $107.29 $264,654 - $344,722	-3,213 Reduced 10.71%	26,799 $2.21 Million
Q2 2022 Aug 09, 2022	BUY	$86.5 - $128.27 $199,209 - $295,405	2,303 Added 8.31%	30,012 $2.85 Million
Q1 2022 May 12, 2022	SELL	$101.96 - $128.34 $88,093 - $110,885	-864 Reduced 3.02%	27,709 $3.26 Million
Q4 2021 Feb 10, 2022	SELL	$106.37 - $130.68 $17.4 Million - $21.4 Million	-164,046 Reduced 85.17%	28,573 $3.7 Million
Q3 2021 Nov 12, 2021	BUY	$102.91 - $122.75 $18.5 Million - $22.1 Million	179,721 Added 1393.4%	192,619 $21.8 Million
Q2 2021 Aug 11, 2021	SELL	$83.84 - $104.76 $68,161 - $85,169	-813 Reduced 5.93%	12,898 $1.34 Million
Q1 2021 May 11, 2021	BUY	$78.68 - $90.67 $363,973 - $419,439	4,626 Added 50.92%	13,711 $1.15 Million
Q4 2020 Feb 11, 2021	SELL	$71.69 - $91.23 $237,867 - $302,701	-3,318 Reduced 26.75%	9,085 $829,000
Q3 2020 Nov 09, 2020	SELL	$67.19 - $87.44 $5.28 Million - $6.87 Million	-78,539 Reduced 86.36%	12,403 $990,000
Q2 2020 Aug 12, 2020	BUY	$57.54 - $76.95 $5.23 Million - $7 Million	90,942 New	90,942 $6.29 Million
Q4 2019 Feb 06, 2020	SELL	$71.7 - $82.09 $231,591 - $265,150	-3,230 Closed	0 $0
Q3 2019 Nov 07, 2019	BUY	$61.55 - $75.43 $198,806 - $243,638	3,230 New	3,230 $710,000
Q2 2019 Aug 08, 2019	SELL	$55.74 - $64.41 $137,677 - $159,092	-2,470 Closed	0 $0
Q1 2019 May 09, 2019	BUY	$47.89 - $64.05 $74,037 - $99,021	1,546 Added 167.32%	2,470 $473,000
Q4 2018 Feb 07, 2019	BUY	$46.41 - $56.94 $42,882 - $52,612	924 New	924 $142,000

Others Institutions Holding EW

# of Institutions

1,352

Shares Held

469M

Call Options Held

9.76M

Put Options Held

3.92M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $42.7B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.

Account

Acadian Asset Management LLC Edwards Lifesciences Corp Transaction History